We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 30, 2020

Amyloid-PET and 18F-FDG-PET for Diagnosing Alzheimer Disease and Other Dementias

The Lancet Neurology


Additional Info

The Lancet Neurology
Amyloid-PET and 18F-FDG-PET in the Diagnostic Investigation of Alzheimer's Disease and Other Dementias
Lancet Neurol 2020 Nov 01;19(11)951-962, G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, E van de Giessen, F Agosta, F Barkhof, DJ Brooks, MC Carrillo, B Dubois, AM Fjell, GB Frisoni, O Hansson, K Herholz, BF Hutton, CR Jack, AA Lammertsma, SM Landau, S Minoshima, F Nobili, A Nordberg, R Ossenkoppele, WJG Oyen, D Perani, GD Rabinovici, P Scheltens, VL Villemagne, H Zetterberg, A Drzezga

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading